Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial.
Faghfouri AH, Khabbazi A, Baradaran B, Khajebishak Y, Baghbani E, Noorolyai S, Rahmani S, Seyyed Shoura SM, Alipour M, Alipour B. Faghfouri AH, et al. Among authors: rahmani s. Clin Nutr. 2022 May;41(5):1083-1092. doi: 10.1016/j.clnu.2022.03.019. Epub 2022 Mar 30. Clin Nutr. 2022. PMID: 35413570 Clinical Trial.
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
Derakhshani A, Asadzadeh Z, Baradaran B, Safarpour H, Rahmani S, Leone P, Abdoli Shadbad M, Hosseinkhani N, Ghasemigol M, Ayromlou H, Ahmadi H, Pouya S, Shojaee M, Tabrizi NJ, Miraki Feriz A, Safarzadeh E, Racanelli V. Derakhshani A, et al. Among authors: rahmani s. Biomed Pharmacother. 2022 Apr;148:112725. doi: 10.1016/j.biopha.2022.112725. Epub 2022 Feb 17. Biomed Pharmacother. 2022. PMID: 35183994 Free article.
Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study.
Baghbani E, Noorolyai S, Rahmani S, Shanehbandi D, Shadbad MA, Aghebati-Maleki L, Mokhtarzadeh A, Brunetti O, Fasano R, Silvestris N, Baradaran B. Baghbani E, et al. Among authors: rahmani s. Biomed Pharmacother. 2022 Jan;145:112370. doi: 10.1016/j.biopha.2021.112370. Epub 2021 Nov 30. Biomed Pharmacother. 2022. PMID: 34862113 Free article.
Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial.
Faghfouri AH, Baradaran B, Khabbazi A, Abdoli Shadbad M, Papi S, Faghfuri E, Khajebishak Y, Rahmani S, Tolou Hayat P, Alipour B. Faghfouri AH, et al. Among authors: rahmani s. Int Immunopharmacol. 2022 Aug;109:108825. doi: 10.1016/j.intimp.2022.108825. Epub 2022 May 10. Int Immunopharmacol. 2022. PMID: 35561480 Clinical Trial.
Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin.
Vazirabad AF, Noorolyai S, Baghbani E, Mahboob S, Zargari F, Rahmani S, Sorkhabi A, Montazami N, Sameti P, Baradaran B. Vazirabad AF, et al. Among authors: rahmani s. Pathol Res Pract. 2022 Dec;240:154194. doi: 10.1016/j.prp.2022.154194. Epub 2022 Nov 3. Pathol Res Pract. 2022. PMID: 36370483
329 results